Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04342429 · ClinicalTrials.gov registry record · NA
Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
A NA study of Small-cell Lung Cancer, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04342429 is a NA study of Small-cell Lung Cancer that is actively recruiting participants, run by Emory University. The registered enrollment target is 30 participants, below the 232-participant average among 79 other Small-cell Lung Cancer trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04342429, a NA study of Small-cell Lung Cancer, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
To assess the safety and efficacy of intensity-modulated proton therapy (IMPT) for small cell lung cancer (SCLC)
Conditions Studied
Interventions
- RADIATION Proton-beam Therapy for Small Cell Lung Cancer
Study Locations (1)
Georgia
- Winship Cancer Institute - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-03-19 |
| Est. Completion | 2027-05-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04342429
The ClinicalTrials.gov registry entry for NCT04342429 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 232-participant average among 79 other Small-cell Lung Cancer trials with a reported enrollment target (87% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Small-cell Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Proton-beam Therapy for Small Cell Lung Cancer is the first listed.
NCT04342429 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT04342429 about?
NCT04342429 is a clinical study titled "Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer". To assess the safety and efficacy of intensity-modulated proton therapy (IMPT) for small cell lung cancer (SCLC)
What is the current status of trial NCT04342429?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2020-03-19. Estimated completion is 2027-05-27.
What conditions does trial NCT04342429 study?
This clinical trial studies the following conditions: Small-cell Lung Cancer.
What interventions are being tested in trial NCT04342429?
The interventions under investigation include: Proton-beam Therapy for Small Cell Lung Cancer (RADIATION).
Who is sponsoring clinical trial NCT04342429?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04342429 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Small-cell Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Hospital-at-Home for People Receiving Tarlatamab
RECRUITING · NA
-
LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)
RECRUITING · NA
-
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
RECRUITING · NA
-
Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases
ACTIVE NOT RECRUITING · NA
-
Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer
COMPLETED · NA
-
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.